News & Events

News

Our latest Press Releases

Tubulis to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target

Fierce Biotech Names Tubulis a “Fierce 15” Biotech Company of 2024

EVENTS

Meet Tubulis live